Has Mary Tran received payments from drug or device companies?

Yes. Drug and device makers reported $7,750 in general payments to Mary Tran across 175 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mary Tran did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mary Tran come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mary Tran

Physician Assistant · San Ramon, CANPI 1891319646

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,826 of the $7,750 with a category attached, or 75.2%. It is spread thinly across 40 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,750in general payments, 2019–2025

Across 175 payments — averaging $44.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$1K
UCB, Inc.$1K
AstraZeneca$634
AbbVie$560
Zynex Medical, Inc.$511
Amgen$459
plus $3K from 34 others

What the payments were for

Consulting fees$1,02013%
Travel & lodging$6899%
Food & beverage$5,82675%
Education$2153%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	17	$1,431
UCB, Inc.	10	$1,254
AstraZeneca(2 entities)	23	$634
AbbVie	17	$560
Zynex Medical, Inc.	1	$511
Amgen	17	$459
Jazz Pharmaceuticals Inc.	8	$430
Johnson & Johnson	3	$349
Regeneron Healthcare Solutions, Inc.	5	$176
Genentech USA, Inc.	6	$170
Sanofi	8	$168
Radius Health, Inc.	6	$129
Novartis	4	$114
GSK	4	$107
Fisher & Paykel Healthcare Inc	2	$91
Boehringer Ingelheim	4	$88
Xeris Pharmaceuticals, Inc.	4	$81
Dexcom, Inc.	2	$75
Kiniksa Pharmaceuticals, Ltd.	2	$68
Madrigal Pharmaceuticals	2	$66
Bayer	3	$60
Almatica Pharma LLC	2	$60
Exact Sciences	2	$59
Aurinia Pharma U.S., Inc.	2	$54
Sanofi-aventis U.S. LLC	2	$47
Kowa Pharmaceuticals America, Inc.	2	$45
Philips North America LLC	1	$45
ARS Pharmaceuticals Operations, Inc.	2	$42
Kiniksa Pharmaceuticals International, PLC	2	$41
Ionis Pharmaceuticals, Inc.	1	$39
Avadel CNS Pharmaceuticals, LLC	1	$38
Galderma Laboratories, L.p.	2	$37
Resmed Corp	1	$34
Lilly USA, LLC	1	$32
Axsome Therapeutics, Inc.	1	$31
Fresenius Kabi USA, LLC	1	$30
Pfizer	1	$29
Takeda Pharmaceuticals U.S.A., Inc.	1	$27
EMD Serono, Inc.	1	$25
ZOLL Respicardia, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire$1,072
Nexwave$511
Tremfya$294
SIMPONI ARIA$294
Rinvoq$250
XYWAV$150
SAPHNELO$132
TEZSPIRE$132
FASENRA$132
AIRSUPRA$132
BREZTRI$132
EVENITY$131

How this compares

$7,750 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Leflunomide	34	$3,059
Hydroxychloroquine Sulfate	43	$1,298
Alendronate Sodium	55	$622
MethotrexateMethotrexate Sodium	40	$439
Gabapentin	31	$247
Allopurinol	30	$223
Diclofenac Sodium	19	$175
Prednisone	44	$98
Folic Acid	11	$38

Paid to pharmacies, not to this prescriber.

Other physician assistant in San Ramon

Andrea NguyenIrvine$1M
Mikhail AlperMadera$889K
Erin JensenUpland$716K
Franklin ClineSacramento$458K
Carla CrespoMarina del Rey$297K
Katherine OsakiEl Centro$274K
Shawna JonesFountain Valley$266K
Heather AustinSalinas$219K
Andrea FoxStanford$172K
Asma HussainiThousand Oaks$102K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →